Fevertree Drinks Plc announce a proposed a final dividend of 24.0p will be paid on 4 December 2026 to the shareholders on the register at the close of business on 13 November 2026.
Other financial highlights include:
US momentum building under the Molson Coors partnership
- Positive operational and strategic progress delivering 11% revenue growth at constant currency.
- Highest ever Ginger Beer and Tonic market share at retail, extending their number one position
- Sales momentum building as thry progress through the year, supported by Fever-Tree's first national US marketing campaign, together with strong distributor execution.
Diversification strategy driving growth
- Fever-Tree brand revenue increased 8% at constant currency, with growth across all regions.
- The UK saw a return to growth, driven by a strong Off-Trade performance and market share gains.
- Continued strong momentum across the portfolio globally, with tonic revenue increasing 3% and the wider portfolio growing 13% and now represents almost half of Group sales.
Cash generative business model supporting growth and shareholder returns
Adjusted EBITDA increased 9% to £20.1 million, including a step-change in US marketing investment.
£60 million share buyback programme underway following the successful £100 million programme completed in FY25, supported by a strong balance sheet and £68 million cash position.
FY26 expectations unchanged
Well hedged with regards to glass and aluminum costs
Our expectations for FY26 remain unchanged and in line with market expectations.
